n-Lorem Foundation Announces the Second Annual Nano-rare Patient Colloquium Will be Held on Oct. 30 & 31, 2024 [Yahoo! Finance]
Ionis Pharmaceuticals, Inc. (IONS)
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ionispharma.com
Company Research
Source: Yahoo! Finance
Register today and join the Community of Care for Nano-rare SAN DIEGO, April 10, 2024 BUSINESS WIRE n-Lorem, a nonprofit foundation , has announced the dates for its second annual Nano-rare Patient Colloquium, which will be held Oct. 30 & 31 in Cambridge, Mass. The Nano-rare Patient Colloquium will bring together a Community of Care for Nano-rare that consists of treating physicians, industry leaders, corporate, foundation and individual supporters, the n-Lorem team and most importantly, nano-rare patients and their families. "At this second annual meeting, we are pleased to share our progress, our aspirations and the important lessons we are learning from our patients, which we believe will reshape how we think about health and disease," said Stanley T. Crooke, M.D., Ph.D., Chairman, Founder, and CEO, n-Lorem Foundation. The 2023 Nano-rare Patient Colloquium was the first of its kind with nano-rare patient families and more than 20 panelists and presenters who led informative
Show less
Read more
Impact Snapshot
Event Time:
IONS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IONS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IONS alerts
High impacting Ionis Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
IONS
News
- Ionis announces pricing of $500.3 million public offeringPR Newswire
- Ionis announces proposed public offering of common stockPR Newswire
- Ionis to present at upcoming investor conferencesPR Newswire
- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its price target raised by analysts at JPMorgan Chase & Co. from $50.00 to $55.00. They now have a "neutral" rating on the stock.MarketBeat
- Ionis Pharmaceuticals: Harnessing RNA-Targeted Therapies For Long-Term Shareholder Value [Seeking Alpha]Seeking Alpha
IONS
Earnings
- 8/1/24 - Beat
IONS
Sec Filings
- 9/12/24 - Form 8-K
- 9/10/24 - Form 424B5
- 9/9/24 - Form 8-K
- IONS's page on the SEC website